Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Papulosquamous » Psoriasis
Description
A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. MeSH
Hierarchy View
Subtype Terms (1)
Arthritis, Psoriatic
74 drugs (53 approved, 21 experimental)
Approved Indicated Drugs (30)
Phase 3 Indicated Drugs (47)
Phase 2 Indicated Drugs (155)
3-(aminocarbonyl)-1-β-d-ribofuranosyl-pyridinium chloride
4,4-dimethyl-benziso-2h-selenazine
Phase 1 Indicated Drugs (85)
Other Experimental Indicated Drugs (15)
Organization Involved with Phase 4 Indications (118)
Bhatia Skin Center, Bima Nagar, Indore
Dr. D. Y. Patil Dental College & Hospital
Dr. Saple's clinic, 88, 3rd Lane, Hindu Colony, Near Bhagini Samaj, Dadar (East), Mumbai-400014
Durgabai Deshmukh Hospital & Research Center
Icahn School of Medicine at Mount Sinai
Istituti Fisioterapici Ospitalieri
Katholieke Universiteit Leuven
Lokmanya Tilak Municipal Medical College
Narrows Institute for Biomedical Research
National Heart, Lung, and Blood Institute (NHLBI)
Novum Pharmaceutical Research Services
Postgraduate Institute of Medical Education and Research
Rajiv Gandhi University of Health Sciences
Renova Skin & Laser Clinic, Jaipur
Shanghai CP Guojian Pharmaceutical Co.,Ltd.
SingHealth Investigational Medicine Unit
Skin & Laser Center, New Delhi
South-Eastern Norway Regional Health Authority
Sri Skin Care & Laser Clinic, Chowk-Lucknow
The Danish Psoriasis Association
The Danish Rheumatism Association
Organization Involved with Phase 3 Indications (146)
Advanced Clinical Research Inc.
Anderson & Collins Clinical Research, Inc.
Atlanta Dermatology, Vein & Research Center
Bakersfield Dermatology and Skin Cancer Medical Group
CABINET BATEAU BLANC - MARTIGUES
Chinese Academy of Medical Sciences
Colorado Medical Research Center, Inc.
David Fivenson, MD Dermatology, PLC
Dawes Fretzin Clinical Research Group
Dermatology Clinical Research Center of San Antonio
Dermatology Research Center, Inc
Eastern Canada Cutaneous Research Associates Ltd.
Great Lakes Research Group, Inc
Gwinnett Clinical Research Center, Inc
Hoosier Cancer Research Network
HOPITAL PRIVE D'ANTONY - ANTONY
Horizons Clinical Research Center, LLC
Hospital Padre Bento de Guarulhos
Indiana Clinical Trials Center
International Dermatology Research Inc.
Izmir Bozyaka Training and Research Hospital
King-Maceyko Dermatology Associates
Kolderma Instituto De Pesquisa Clinica
Mantecorp Industria Quimica e Farmaceutica Ltd.
Minnesota Clinical Study Center
North Florida Dermatology Associates
Oregon Dermatology and Research Center
Owensboro Dermatology Associates
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd
Skin Surgery Medical Group, Inc.
Triangle Medical Research Associates, LLC
Universitaetsklinikum Schleswig-Holstein
Universitair Medisch, Afdeling Dermatologie
University of Modena and Reggio Emilia
University of Nice Sophia Antipolis
University of Picardie Jules Verne
University of Western Brittany
Ventana Clinical Research Corporation
Organization Involved with Phase 2 Indications (156)
Aurigene Discovery Technologies
AUTOMATIC SUBDERMAL INJECTOR SYSTEM, INC
AVVAA World Healthcare Products, Inc.
Betta Pharmaceuticals Co.,Ltd.
BioMimetix Pharmaceutical, Inc.
Case Western Reserve University
Centre de Recherche Dermatologique du Quebec Metropolitaine
Gansu University of Chinese Medicine
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangxi Zhuang Autonomous Region Dermatology Hospital
Heilongjiang University of Traditional Chinese Medicine
Hemay Pharmaceutical PTY. LTD.
Huazhong University of Science and Technology
Immune Technologies & Medicine GmbH
Klinik für Dermatologie, Venerologie und Allergologie
LAL Clinical Reseach e Development Ltda
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National University of Ireland
Oregon Health and Science University
Oregon Medical Research Center
People's Liberation Army of China
Philippine Dermatological Society
Provectus Biopharmaceuticals, Inc.
Psoriasis Research Institute of Guangzhou
Shanghai University of Traditional Chinese Medicine
Shijiazhuang Hospital of Traditional Chinese Medicine
State University of New York, Brooklyn
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Technical University of Dresden
University of California, Davis
University of California, Irvine
University of California, San Diego
University of Erlangen-Nuremberg
University of Medicine and Dentistry of New Jersey
Organization Involved with Phase 1 Indications (54)
Organization Involved with Other Experimental Indications (35)
Centre for Dermatology and Sexually Transmitted Diseases, Astana, Kazakhstan
Centre Hospitalier Universitaire de Nīmes
National Center for Research Resources (NCRR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
